Trials / Completed
CompletedNCT07098117
A Randomized, Double-blind, Placebo-controlled Phase I Clinical Trial to Evaluate the Safety and Pharmacokinetic Profile of Single and Multiple Dose Escalation Topical Dermal Administration of SHR0302 Alkali Gel in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This study is divided into two parts, the first part is a single-dose dose escalation trial (SAD) in healthy subjects; The second part is a multiple-dose dose escalation trial (MAD) in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SHR0302 Base Gel | Part I: once daily. Part 2:, twice daily. |
| DRUG | SHR0302 Base Gel Placebo | Part I: once daily. Part II: twice daily. |
Timeline
- Start date
- 2024-06-19
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
- First posted
- 2025-08-01
- Last updated
- 2025-08-01
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07098117. Inclusion in this directory is not an endorsement.